<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee18037e6e5">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2000-12-13</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>40 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-01-21</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-21</identifier>
<identifier type="local">P0b002ee18037e6e5</identifier>
<identifier type="former package identifier">f:d0121</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-28</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-01-21</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-01-21</accessId>
 <reportNumber>GAO-01-21</reportNumber>
 <subject>Immunization services</subject>
 <subject>Terrorism</subject>
 <subject>Embassies</subject>
 <subject>Immunization programs</subject>
 <subject>Biological warfare</subject>
 <subject>Americans employed abroad</subject>
 <subject>Military intelligence</subject>
 <identifier>Dept. of State Anthrax Vaccine Immunization Program</identifier>
 <identifier>CDC/FDA Vaccine Adverse Events Reporting System</identifier>
 <type>Letter Report</type>
</extension>
<titleInfo>
 <title>State Department: Serious Problems in the Anthrax Vaccine</title>
</titleInfo>
<abstract>In 1998, the State Department stockpiled anthrax vaccine and antibiotics
at several diplomatic posts near Iraq. In the event of an anthrax attack
by Iraq, this stockpile was to be used for post-exposure immunization
and treatment. In 1999, the State announced that it was starting a
voluntary Anthrax Immunization Program for U.S. government employees,
their dependents, and other personnel serving overseas. According to the
Food and Drug Administration (FDA), full pre-exposure protection from
anthrax requires six vaccinations given over an 18-month period,
followed by an annual booster. Because there were insufficient supplies
of vaccines approved by the FDA, State decided to suspend plans to
expand the program beyond the pilot site until more vaccine was
available. GAO found that both the State Department&apos;s prepositioning of
anthrax vaccine at diplomatic missions and the voluntary anthrax
immunization program have been poorly implemented. Specifically, the
vaccine was not properly stored or refrigerated, requirements for the
voluntary program were not accurately estimated, and surveillance
procedures used in the pilot program to monitor reactions to the vaccine
were inadequate.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-01-21/html/GAOREPORTS-GAO-01-21.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-01-21/pdf/GAOREPORTS-GAO-01-21.pdf</url>
</location>
<identifier type="preferred citation">GAO-01-21</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-21</url>
</location>
<note>Letter Report</note>
<extension>
 <searchTitle>GAO-01-21; State Department: Serious Problems in the Anthrax Vaccine;
            </searchTitle>
</extension>
<subject>
 <topic>Immunization services</topic>
 <topic>Terrorism</topic>
 <topic>Embassies</topic>
 <topic>Immunization programs</topic>
 <topic>Biological warfare</topic>
 <topic>Americans employed abroad</topic>
 <topic>Military intelligence</topic>
 <topic>Dept. of State Anthrax Vaccine Immunization Program</topic>
 <topic>CDC/FDA Vaccine Adverse Events Reporting System</topic>
</subject>
</mods>